Form 4/A for RCEL AVITA Medical, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-21 · accession 0000950170-23-072730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-12-22 | 2023-12-21 | RCEL | COOK JEREMY CURNOCK | Dir | S - Sale | $12.49 | -2,500 | 20.6K | -11% | -$31.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2023-12-21 | S | D | 2,500 | $12.49 | 20,614 | D | — | — | (F2) The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction. (F1) Shares sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4. (F4) Includes unvested RSUs |